Biotechnology
Eli Lilly to invest another $5.3 billion in Indiana plant to expand Mounjaro, Zepbound supply
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly on Friday said it is investing another $5.3 billion in a manufacturing plant in Lebanon, Indiana to boost supply of its highly popular weight loss drug Zepbound, diabetes treatment […]
Read More
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to rebound from the rapid decline of its Covid business. The announcement is in addition […]
Read More
FDA approves Amgen’s treatment for most deadly form of lung cancer
The Amgen headquarters in Thousand Oaks, California. Eric Thayer | Bloomberg | Getty Images The Food and Drug Administration on Thursday approved Amgen‘s therapy for patients with the most deadly form of lung cancer. The agency cleared the drug, which will be marketed under the name Imdelltra, as a second or later line of treatment […]
Read More
Roche says weight loss drug shows promising results in early trial
A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024. Bloomberg | Getty Images Roche on Thursday said its experimental weight loss drug showed promising results in an early-stage trial, boosting the company’s bid to compete in the booming market for those treatments. The Swiss company joined a slate of […]
Read More
Danaher’s rally shows how sticking with a troubled stock of a good company can pay off
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. (We’re no longer recording the audio, so we can get this new written feature to members as quickly as possible.) Market talk : The S & […]
Read More
Walgreens to offer its own cheaper version of opioid overdose reversal drug naloxone
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Wednesday said it will offer its own cheaper version of the over-the-counter opioid overdose reversal spray naloxone. The drug is available online and will be in all […]
Read More
People on Novo Nordisk’s Wegovy maintain weight loss for up to four years, study says
Boxes of Wegovy made by Novo Nordisk are seen at a pharmacy in London, Britain March 8, 2024. Hollie Adams | Reuters Patients taking Novo Nordisk‘s obesity drug Wegovy maintained an average of 10% weight loss for up to four years, according to a new analysis published Tuesday from the longest clinical trial to date […]
Read More
Novavax stock jumps 50% as Sanofi offer kicks off turning issue for battling vaccine maker
A vial labelled “Novavax V COVID-19 Vaccine” is witnessed in this illustration taken January 16, 2022. Dado Ruvic | Reuters Shares of Novavax jumped as a lot as 50% on Monday as Wall Road cheered the firm’s new multibillion-dollar offer with French drugmaker Sanofi that sparked a spectacular turnaround for the having difficulties vaccine maker. […]
Read More
Moderna says FDA delayed RSV vaccine approval to end of May
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency. The FDA was expected to make a decision on the RSV shot on Sunday. The agency […]
Read More
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company’s Covid […]
Read More